TY - JOUR
T1 - Safety of neuraminidase inhibitors for influenza
AU - Jones, Mark
AU - Del Mar, Chis
N1 - reproduces with permission
From: Crone, Jane [[email protected]]
Sent: Thursday, 14 September 2006 11:32 PM
To: Yvonne Auld
Subject: RE: Requesting Permission to Archive in Bond University's Institutional Repository
Follow Up Flag: Follow up
Flag Status: Red
Dear Yvonne
Thank you for your enquiry. In this instance we give permission to use the aforementioned article as described in your email below, including acknowledgement to 'Informa Healthcare, Informa UK Ltd' as publisher and link to our website www.expertopin.com .
Regards
Jane Crone
Administrator - Expert Opinion
Informa Healthcare
Telephone House
69-77 Paul Street
London EC2A 4LQ
Tel: +44 (0)20 7017 6874
Fax: +44 (0)20 7017 7667
Email: [email protected]
-----Original Message-----
From: Yvonne Auld [mailto:[email protected]]
Sent: 29 August 2006 08:28
To: Crone, Jane
Subject: Requesting Permission to Archive in Bond University's Institutional Repository
Attention: Permissions Manager
Requesting Permission to Archive in Bond University’s Institutional Repository
Permission is requested on behalf of author Professor Chris Del Mar to deposit an electronic version of an article from
Expert Opinion on Drug Safety in Bond University’s Institutional Repository e-publications@bond for educational and research purposes.
The institutional repository, e-publications@bond is a non profit service designed to showcase research and scholarship emanating from Bond University and facilitate open access for educational and research purposes. No charge is made for the use of any of the material deposited.
Permission is requested to archive the following article:
Jones M, Del Mar C. Safety of neuraminidase inhibitors for influenza. Expert Opin Drug Saf 2006;5:603-8.
If this request is approved we would acknowledge you as the publisher and link to your site as required. If permission is granted, could we post an exact electronic copy of the published version of the document?
Could you advise if you have a generic permissions policy regards author archiving in their institutional repositories?
e-publications@bond is maintained by the Bond University Library.
Thank you for your assistance in this matter.
Yvonne Auld
PY - 2006/9
Y1 - 2006/9
N2 - Neuraminidase inhibitors, oseltamivir and zanamivir, are used for the treatment of, and protection from, influenza. The safety of these compounds has been assessed in systematic reviews. However, the data presented are somewhat limited by the paucity of good quality adverse event data available. The majority of safety outcomes are based on evidence from just one or two randomised controlled trials. The results of the systematic reviews suggest that neuraminidase inhibitors have a reasonable side effect and adverse effect profile if they are to be used to treat or protect patients against a life-threatening disease. However, if these compounds are to be prescribed in situations in which avoidance of inconvenience or minor discomfort is hoped for, then the balance of harms to benefits will be more difficult to judge.
AB - Neuraminidase inhibitors, oseltamivir and zanamivir, are used for the treatment of, and protection from, influenza. The safety of these compounds has been assessed in systematic reviews. However, the data presented are somewhat limited by the paucity of good quality adverse event data available. The majority of safety outcomes are based on evidence from just one or two randomised controlled trials. The results of the systematic reviews suggest that neuraminidase inhibitors have a reasonable side effect and adverse effect profile if they are to be used to treat or protect patients against a life-threatening disease. However, if these compounds are to be prescribed in situations in which avoidance of inconvenience or minor discomfort is hoped for, then the balance of harms to benefits will be more difficult to judge.
UR - http://www.scopus.com/inward/record.url?scp=33747499143&partnerID=8YFLogxK
U2 - 10.1517/14740338.5.5.603
DO - 10.1517/14740338.5.5.603
M3 - Review article
C2 - 16907649
AN - SCOPUS:33747499143
SN - 1474-0338
VL - 5
SP - 603
EP - 608
JO - Expert Opinion on Drug Safety
JF - Expert Opinion on Drug Safety
IS - 5
ER -